Skip to content

Vectura

  • Services
    • Services Overview
    • Formulation
    • Pharmaceutical analysis
    • Device platforms
    • Process development & technical transfer
    • Product manufacturing
    • Regulatory Services
  • Product Development
  • Our Science
  • About
    • About overview
    • News
    • Track Record
    • Leadership team
    • Vectura Fertin Pharma
    • PMI Offer
    • Meetings & Voting
    • ESG Strategy
  • Contact
  • Investors archive
    • RNS updates
    • Shareholder information
    • Analyst coverage
    • Financial reports and presentations
    • Investment case
    • Governance
    • Skyepharma
    • Historical Share Offerings

Services

Progress your programme with our unique combination of inhaled development expertise, formulation science and device technology. We offer a fully-integrated approach to support you in the development of your inhaled medicine.

Services

Development

Services OverviewFormulationPharmaceutical analysisDevice platforms

Manufacturing

Process development & technical transferProduct manufacturing

Regulatory

Regulatory Services

About

Inhalation is our focus. With more than 20 years’ experience, we can help you succeed in bringing inhaled medicines to market.

About

Updates

News

About Vectura

Track RecordLeadership team

Financial Information

Vectura Fertin PharmaPMI OfferMeetings & VotingESG Strategy

Investors archive

The information displayed in this section is historical information.

Investors archive

Stocks

RNS updates

Shareholders

Shareholder informationAnalyst coverage

Reports

Financial reports and presentations

Investors

Investment caseGovernance

Archive

SkyepharmaHistorical Share Offerings
ServicesProduct DevelopmentOur ScienceAboutContactInvestors archive
Back
Development
Services OverviewFormulationPharmaceutical analysisDevice platforms
Manufacturing
Process development & technical transferProduct manufacturing
Regulatory
Regulatory Services
Back
Updates
News
About Vectura
Track RecordLeadership team
Financial Information
Vectura Fertin PharmaPMI OfferMeetings & VotingESG Strategy
Back
Stocks
RNS updates
Shareholders
Shareholder informationAnalyst coverage
Reports
Financial reports and presentations
Investors
Investment caseGovernance
Archive
SkyepharmaHistorical Share Offerings

Site map

 

  •  Home
    • Services
      • Formulation
      • Pharmaceutical Analysis
      • Device Platforms
      • Process Development & Technical Transfer
      • Product Manufacturing
      • Regulatory Services
    • Product Development
    • Our Science
    • About
      • News
    • Contact
    • Investors
      • Detailed Share Price
      • Investment Case
      • Governance
      • Meetings & Voting
      • Shareholder Information
      • Analyst Coverage
      • Skyepharma merger
      • Historical Share Offerings
      • Financial Reports and Presentations
      • Financial Press Releases
      • Financial Calendar
      • RNS email alerts form
      • Board and Leadership team
    • Accessibility
    • Terms and Conditions
    • Privacy Policy
    • Cookie Policy
    • Instruction manuals for devices
    • Services
    • Product Development
    • Our Science
    • About
    • Contact
    • Investors archive
  • Careers
    • Vectura Fertin Pharma
    • Accessibility
    • Commitment to inclusivity
    • Modern Slavery Act
    • Gender pay gap
    • Supplier Terms and Conditions
    • Tax strategy
    • Privacy policy
    • Website Terms & Conditions
    • Cookie Statement
    • Site map
    • Breelib™ Instructions for Use
    • FOX® Mobile Instructions for use
    • AKITA® JET Inhalation System Instructions for Use

©2023 Vectura Group Ltd

Designed and Developed by Naked Ideas